CIAM
IMNM icon

Caitong International Asset Management’s Immunome IMNM Stock Holding History

Caitong International Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Buy
12,863
+12,119
+1,629% +$270K 0.05% 304
2025
Q4 		$16K Buy
+744
New +$13.1K ﹤0.01% 1042
2025
Q3 		– Sell
-610
Closed -$5.67K – 2214
2025
Q2 		$5.67K Buy
610
+419
+219% +$3.44K ﹤0.01% 966
2025
Q1 		$1.28K Buy
191
+85
+80% +$816 ﹤0.01% 1498
2024
Q4 		$1.13K Buy
+106
New +$1.28K ﹤0.01% 1304

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Caitong International Asset Management's IMNM Position: Q1 2026 in Review

Caitong International Asset Management increased its Immunome (IMNM) stake by 1,629% in Q1 2026, buying an estimated $270K and bringing the position to 12,863 shares worth $281K. The position accounts for 0.05% of the portfolio, ranked #304.

Caitong International Asset Management first reported a position in IMNM in Q4 2024 and has held it in 5 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Caitong International Asset Management held 12,863 shares of Immunome worth $281K as of Q1 2026.
  • Caitong International Asset Management bought 12,119 Immunome shares in Q1 2026, an estimated $270K.
  • Immunome made up 0.05% of Caitong International Asset Management's portfolio in Q1 2026, its #304 holding.
  • Caitong International Asset Management first reported a position in Immunome in Q4 2024 and has held it in 5 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.